MedinotecMDNC 24 PB Ratio is 10.29 as of Jun. 27, 2026, which is 50% below its 10-year median of 20.75. GuruFocus rates MDNC with a GF Score™ of 24/100. The stock has 2 warning signs investors should review.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-27), Medinotec's share price is $5.00. Medinotec's Book Value per Share for the quarter that ended in Feb. 2026 was $0.49. Hence, Medinotec's PB Ratio of today is 10.29.
Good Sign:
Medinotec Inc stock PB Ratio (=10.29) is close to 3-year low of 10.29.
The historical rank and industry rank for Medinotec's PB Ratio or its related term are showing as below:
MDNC'
s PB Ratio Range Over the Past 10 Years
Min: 10.29 Med: 20.75 Max: 28.25
Current: 10.29
During the past 5 years, Medinotec's highest PB Ratio was 28.25. The lowest was 10.29. And the median was 20.75.
During the past 12 months, Medinotec's average Book Value Per Share Growth Rate was 33.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 30.60% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Medinotec was 30.60% per year. The lowest was 30.60% per year. And the median was 30.60% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Medinotec PB Ratio Related Terms
Medinotec PB Ratio Historical Data
* Premium members only.
The historical data trend for Medinotec's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medinotec's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medinotec PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medinotec's PB Ratio distribution charts can be found below:
* The bar in red indicates where Medinotec's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Medinotec's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Medinotec (MDNC) has a PB Ratio of 10.29 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medinotec and its competitors. This is 50% below median its historical median of 20.75. Over the past decade, Medinotec's PB Ratio has ranged from 10.29 to 28.25.
Is Medinotec's PB Ratio too high?
Medinotec's current PB Ratio of 10.29 is 50% below median its 10-year median of 20.75. Over the past 10 years, this metric has ranged from a low of 10.29 to a high of 28.25. The Medical Devices & Instruments industry median PB Ratio is 2.02. Medinotec's value of 10.29 is 409.4% above this industry median. Overall, Medinotec has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Medinotec's PB Ratio compare to NVNO and APYX?
Medinotec's PB Ratio of 10.29 can be compared against companies in the Medical Devices & Instruments industry. The industry median PB Ratio is 2.02. Medinotec's value of 10.29 is 409.4% above this benchmark. Historically, Medinotec's own PB Ratio has ranged from 10.29 to 28.25 over the past decade. While the company's 10-year median is 20.75 vs. the industry median of 2.02, Medinotec has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medinotec's current PB Ratio of 10.29 is 409.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medinotec and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medinotec's current PB Ratio is 10.29, which is 50% below median its own 10-year median of 20.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinotec stock overvalued right now?
Medinotec (MDNC) has a current PB Ratio of 10.29. The current PB Ratio is 10.29, which is 50% below median its 10-year median of 20.75 and 409.4% above the Medical Devices & Instruments industry median of 2.02. Medinotec's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Medinotec (MDNC), the current PB Ratio is 10.29 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medinotec Inc is a medical device manufacturing and distribution company engaged in tracheal non-occlusive airway dilation technology and medical device design. It generates revenue from two sources: internally designed and manufactured medical devices and distribution of third-party medical products under exclusive or non-exclusive agreements in defined territories. Its products include the Trachealator, the Outflo Aortic Valve Dilation Balloon Catheter, and the Cape Cross family of PTCA balloon catheters. It also distributes a range of cardiology and renal dialysis products on behalf of multinational manufacturers, mainly in South Africa. Its segments are Inside the United States and Outside the United States, with Outside the United States generating maximum revenue.
24GF Score
Get the complete analysis for MDNC
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDNC has been successfully added to your 
